Dr. Gilbert Hosts: Parkinson's disease research at the NIH with Dr. Walter Koroshetz

Join us for the next episode of Dr. Gilbert Hosts when we speak with Dr. Walter Koroshetz, Director of the National Institute of Neurological Disorders and Stroke (NINDS) for a discussion about Parkinson's disease research at the NIH.

For your convenience, we’ve broken down the session by timecode, so you can skip or revisit sections and questions that interest you most. Simply fast-forward the video to the time indicated below:

04:50 Dr. Koroshetz presentation

25:15 When will the National Institutes of Health (NIH) increase the current funding of 200 million dollars a year for Parkinson's disease (PD)?

27:37 You mentioned that Congress has mandated money for dementia research. Why can’t that money be used for any PD research, since the underlying pathology that causes the dementia of PD also causes many of the other issues of PD as well?

30:50 How do people with PD find out about clinical trials being conducted at the NIH?

32:34 What are your thoughts on requiring researchers to share clinical trial results with participants?

36:57,Are there opportunities for the National Institute of Neurologic Disorders (NINDS) to issue specific Requests for Applications (RFAs) for topics within the field of PD research?

43:30 Is there NIH funding for research on COVID-19 and neurologic diseases, specifically long haul symptoms of COVID?

47:28 Could any of the practices that led to the very fast release of COVID-19 vaccines be applied to PD research?

51:08 When will the Environmental Protection Agency (EPA) finally ban paraquat? Does the NIH have any control over that?

55:07 How can the PD community best make our voices heard to the NIH and those that conduct PD research?